Possibility of using a combination of interferon alpha-2b and a complex immunoglobulin drug for infectious diseases in children
DOI: https://dx.doi.org/10.18565/pharmateca.2023.14.15-18
E.B. Belan, E.M. Nikiforova
Volgograd State Medical University, Volgograd, Russia
Combination of interferon alpha-2b and a complex immunoglobulin preparation containing antibodies to a wide range of infections. The use of the drug in acute infectious diseases in addition to standard therapy accelerates the recovery of patients. Prophylactic use of a combination of interferon alfa-2b and a complex immunoglobulin preparation at the stage of clinical remission reduces the frequency and duration of symptoms in frequently ill children.
About the Autors
Corresponding author: Eleonora B. Belan, Dr. Sci. (Med.), Professor, Head of the Department of Immunology and Allergology, Volgograd State Medical University, Volgograd, Russia; belan.eleonora@yandex.ru
Similar Articles